Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0055 AUD | +10.00% | +10.00% | +10.00% |
05-08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
03-05 | Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+10.00% | 21.47M | |
+30.61% | 49.46B | |
+1.20% | 42.58B | |
+49.11% | 42.49B | |
-5.26% | 29.09B | |
+12.78% | 26.61B | |
-23.81% | 18.64B | |
+7.35% | 13.16B | |
+31.42% | 12.55B | |
+23.07% | 12.1B |
- Stock Market
- Equities
- IVX Stock
- News Invion Limited
- Invion's Cancer Drug Regresses Tumor, Triggers Immune Response in Animal Study; Shares Surge 131%